Fate Therapeutics (FATE)
(Real Time Quote from BATS)
$1.59 USD
-0.02 (-1.24%)
Updated Dec 30, 2024 12:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 2/24/25 |
---|---|
Current Quarter | -0.44 |
EPS Last Quarter | -0.40 |
Last EPS Surprise | 4.76% |
ABR | 2.33 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.72 |
Next Year | -1.72 |
EPS (TTM) | -1.65 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.48M | 1.00M | 12.36M | 3.60M |
# of Estimates | 4 | 1 | 7 | 3 |
High Estimate | 3.23M | 1.00M | 15.00M | 4.00M |
Low Estimate | 0.80M | 1.00M | 10.70M | 3.20M |
Year ago Sales | 1.68M | 1.93M | 63.53M | 12.36M |
Year over Year Growth Est. | -11.79% | -48.19% | -80.55% | -70.87% |
Earnings Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.44 | -0.46 | -1.72 | -1.72 |
# of Estimates | 9 | 5 | 11 | 10 |
Most Recent Consensus | -0.41 | -0.42 | -1.64 | -1.78 |
High Estimate | -0.39 | -0.40 | -1.18 | -0.80 |
Low Estimate | -0.48 | -0.50 | -2.62 | -2.11 |
Year ago EPS | -0.45 | -0.47 | -1.64 | -1.72 |
Year over Year Growth Est. | 2.22% | 2.13% | -4.88% | 0.19% |
Agreement - Estimate Revisions
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 0 | 5 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 2 | 1 | 2 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.44 | -0.46 | -1.72 | -1.72 |
7 Days Ago | -0.44 | -0.46 | -1.72 | -1.72 |
30 Days Ago | -0.44 | -0.46 | -1.72 | -1.72 |
60 Days Ago | -0.42 | -0.42 | -1.73 | -1.69 |
90 Days Ago | -0.42 | -0.42 | -1.73 | -1.69 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.44 | -0.46 | -1.72 | -1.72 |
Zacks Consensus Estimate | -0.44 | -0.46 | -1.72 | -1.72 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (9/2024) |
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.40 | -0.33 | -0.47 | -0.45 | NA |
Estimate | -0.42 | -0.47 | -0.47 | -0.57 | NA |
Difference | 0.02 | 0.14 | 0.00 | 0.12 | 0.07 |
Surprise | 4.76% | 29.79% | 0.00% | 21.05% | 13.90% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more